Abbott: FDA approves TactiCath Contact Force Ablation Catheter

Abbott announced FDA approval of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, a new ablation catheter “designed to help physicians accurately and effectively treat atrial fibrillation.” The company added, “The approval further expands Abbott’s portfolio of cardiac ablation tools that integrate with the company’s EnSite Precision cardiac mapping system to help physicians develop more precise images of the heart during cardiac ablation procedures.”
https://thefly.com/landingPageNews.php?id=2851241